Beam Therapeutics CEO John Evans sells $1.19m in company stock

Blue Owl Founders Promised a Comeback. The Company’s Share Price Hasn’t Budged.

Dow Jones · Markets 26m ago

Goldcana plans C$1 million flow-through private placement

Investing.com · News 37m ago

Adaptive biotechnologies president & COO Rubinstein sells $897k stock

Investing.com · News 40m ago

Zone Frontier CEO Tyler Hassen buys $55,150 in common stock

Investing.com · News 40m ago

Iran war: Missiles target Saudi oil hub as Yemen conflict escalates

Investing.com · News 46m ago

Blaize declares preferred stock dividend ahead of potential reverse split

Investing.com · News 49m ago

Kratos Defense’s president Carrai disposes of $259,116 in common stock

Investing.com · News 54m ago

BillionToOne CEO Oguzhan Atay sells $1.09 million in stock

Investing.com · News 54m ago

StandardAero’s chief legal officer sells $16,567 in company stock

Investing.com · News 55m ago

Prediction: Alphabet Will Be a Larger Company Than Apple by the End of 2027

NASDAQ · Markets 57m ago